CK Life Sciences Int'l., (Holdings) Inc.

HKEX:0775.HK

0.405 (HKD) • At close December 24, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001
Revenue 5,322.7335,275.595,402.3124,942.5444,967.0245,232.9924,693.1334,868.544,919.3094,954.0434,970.9274,545.0223,511.5632,694.2042,678.8892,991.7972,091.5922,197.118694.379329.62727.5634.9480.148
Cost of Revenue 3,685.5253,649.6043,772.3423,535.6383,360.2873,498.6283,149.3223,207.4483,177.4623,213.7213,229.1132,992.2162,331.4321,872.1521,839.1332,084.2171,355.5391,369.928386.536134.50617.6893.5330.103
Gross Profit 1,637.2081,625.9861,629.971,406.9061,606.7371,734.3641,543.8111,661.0921,741.8471,740.3221,741.8141,552.8061,180.131822.052839.756907.58736.053827.19307.843195.1219.8741.4150.045
Gross Profit Ratio 0.3080.3080.3020.2850.3230.3310.3290.3410.3540.3510.350.3420.3360.3050.3130.3030.3520.3760.4430.5920.3580.2860.304
Reseach & Development Expenses 145.874158.535157.269149.773122.284151.835174.283170.475183.125190.823225.503000000000000
General & Administrative Expenses 82.22778.75390.99600000000000000000000
Selling & Marketing Expenses 52.74959.32171.29100000000000000000000
SG&A 134.976138.074553.161538.9711,107.0471,248.7941,134.5991,104.6521,102.059497.986489.963000000000000
Other Expenses 01,245.827685.852647.793650.042-774.933-781.086-710.965-782.081-825.622-852.756-644.717-494.125-439.597-494.779-11.42668.131683.80233.594193.8639.21761.8957.941
Operating Expenses 739.2551,383.901685.852647.793650.042584.605586.662592.014553.427565.039560.208508.044434.752140.776120.7441,144.843668.131683.80233.594193.8639.21761.8957.941
Operating Income 223.848339.625336.062247.852376.319555.673423.788475.43415.975413.829392.334390.417250.523241.687233.441-258.56162.412146.318274.2491.2580.657-60.475-57.896
Operating Income Ratio 0.0420.0640.0620.050.0760.1060.090.0980.0850.0840.0790.0860.0710.090.087-0.0860.030.0670.3950.0040.024-12.222-391.189
Total Other Income Expenses Net -155.264-726.03-662.898-597.461-714.769-636.561-532.21645.126-117.527-730.383-17.255-89.404-89.164-457.01-18.11-66.982-34.93-34.936-44.322-3.8770.041-28.5890
Income Before Tax 68.584204.864238.239119.126217.435421.226329.993360.75341.442321.13303.729301.013161.359224.266215.331-325.54332.99298.44516.1464.2810.698-89.064-57.896
Income Before Tax Ratio 0.0130.0390.0440.0240.0440.080.070.0740.0690.0650.0610.0660.0460.0830.08-0.1090.0160.0450.0230.0130.025-18-391.189
Income Tax Expense 51.33472.91275.438-6.10227.474120.53749.44894.52472.77848.37869.183102.97946.25225.59729.27127.54-82.3191.6535.3683.551-0.041-0.0520.038
Net Income 17.25131.963162.801125.234181.735263.001258.402251.971284.912263.558229.008176.331125.826208.551187.098-351.768117.001102.02210.7780.730.698-89.012-57.934
Net Income Ratio 0.0030.0250.030.0250.0370.050.0550.0520.0580.0530.0460.0390.0360.0770.07-0.1180.0560.0460.0160.0020.025-17.989-391.446
EPS 0.0020.0140.0170.0130.0190.0270.0270.0260.0230.0270.0240.0180.0130.0220.02-0.0370.0120.0120.002-0.0010-0.014-0.01
EPS Diluted 0.0020.0140.0170.0130.0190.0270.0270.0260.0230.0270.0240.0180.0130.0220.02-0.0370.0120.0120.002-0.0010-0.014-0.01
EBITDA 624.75469.508449.145353.619475.211521.022327.453452.06433.715446.736457.481493.532352.273336.25341.33-166.081147.965204.56472.28625.08722.446-42.292-51.228
EBITDA Ratio 0.1170.1080.1080.0950.1170.1330.1210.1260.110.1110.1060.1090.10.1250.127-0.0490.0680.0980.4430.0760.814-8.547-346.135